Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Hypoxia in the Tumour Microenvironment and the Interplay between the Hypoxia Inducible Factor and Aryl Hydrocarbon Receptor Pathways

EF 2018-19

Résumé
The 5-year survival rates for pancreatic cancer are among the lowest of any cancer type and patients are resistant to most therapies. Interestingly, pancreatic cancer is characterized by a significant amount of immune cells infiltrating the tumour. This is encouraging since immune cells play a crucial role in fighting many cancers. However, certain immune cells can also suppress the immune response to cancer. In pancreatic cancer, macrophages, a type of immune cell, are important suppressors of the immune system. The aryl hydrocarbon receptor (AhR) cell-signalling pathway plays a crucial role in determining whether macrophages will suppress the immune system, or lead to an inflammatory state that is favourable for clearing tumours. Our lab has shown that AhR is essential for desirable, suppressive macrophage function in autoimmune disease. Thus, eliminating AhR may relieve suppression of the immune system and lead to a better anti-tumour response in a cancer setting. Preliminary data supports this line of thinking, but macrophage signalling is complex; the AhR pathway is closely intertwined with the hypoxia inducible factor (HIF) pathway. HIF is also of interest because tumours are characterized by a lack of oxygen (hypoxia), which triggers HIF. There is evidence that the HIF and AhR pathways play opposing roles in macrophages. We aim to reveal the different roles hypoxia, HIF, and AhR play in polarizing macrophages towards either an inflammatory or suppressive subtype. Being able to control the immune suppressive vs. inflammatory function of macrophages by drugging HIF and AhR will be useful not only in the treatment of cancer, but other diseases characterized by hypoxia, such as irritable bowel disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
406255
Name
Neufeld Luke A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Hypoxia in the Tumour Microenvironment and the Interplay between the Hypoxia Inducible Factor and Aryl Hydrocarbon Receptor Pathways
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Metabolism; Cell Signalling; Hypoxia; Immune Suppression; Immune Tolerance; Immunotherapy; Macrophages; Myeloid Cells; Pancreatic Cancer; Tumour Microenvironment
Abstract
The 5-year survival rates for pancreatic cancer are among the lowest of any cancer type and patients are resistant to most therapies. Interestingly, pancreatic cancer is characterized by a significant amount of immune cells infiltrating the tumour. This is encouraging since immune cells play a crucial role in fighting many cancers. However, certain immune cells can also suppress the immune response to cancer. In pancreatic cancer, macrophages, a type of immune cell, are important suppressors of the immune system. The aryl hydrocarbon receptor (AhR) cell-signalling pathway plays a crucial role in determining whether macrophages will suppress the immune system, or lead to an inflammatory state that is favourable for clearing tumours. Our lab has shown that AhR is essential for desirable, suppressive macrophage function in autoimmune disease. Thus, eliminating AhR may relieve suppression of the immune system and lead to a better anti-tumour response in a cancer setting. Preliminary data supports this line of thinking, but macrophage signalling is complex; the AhR pathway is closely intertwined with the hypoxia inducible factor (HIF) pathway. HIF is also of interest because tumours are characterized by a lack of oxygen (hypoxia), which triggers HIF. There is evidence that the HIF and AhR pathways play opposing roles in macrophages. We aim to reveal the different roles hypoxia, HIF, and AhR play in polarizing macrophages towards either an inflammatory or suppressive subtype. Being able to control the immune suppressive vs. inflammatory function of macrophages by drugging HIF and AhR will be useful not only in the treatment of cancer, but other diseases characterized by hypoxia, such as irritable bowel disease.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Neufeld, Luke A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~